PubHawk
Biomed Pharmacother November 2018 PMID 30257383

Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives.

Paramita Basu, Camelia Maier

Full text PDF Download social card

Mentions

6
Peak: 2 in Oct 2022
across 3 sources since Mar 2020

Extended reach

303,579
potential audience

Total likes

6,760

Video views

301,838

Mentions per month

Mar 2020 – Oct 2022

Where it's discussed

  • News3 articles
  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussion highlights the potential of phytoestrogens to inhibit estrogen synthesis, with phrasing like 'podrían inhibir' indicating cautious optimism. The tone remains speculative and straightforward, illustrating a mild interest without extensive analysis or engagement.

AgreementModerate agreement

The post suggests that phytoestrogens could inhibit estrogen synthesis and metabolism, aligning with the article's findings on their potential anti-breast cancer effects, which indicates moderate agreement.

InterestNeutral interest

The discussion shows a neutral stance, primarily noting a possible effect rather than exploring broader implications or detailed mechanisms.

EngagementNeutral engagement

The comment is brief and theoretical, reflecting minimal deep engagement with the specific science or broader context.

ImpactNeutral impact

As a single, tentative comment, it doesn't suggest a significant impact on the field or policy, but rather a casual observation.

Abstract in brief

  • Phytoestrogens are plant-derived compounds that mimic the hormone estrogen and can influence breast cancer cell growth by binding to estrogen receptors, potentially acting as estrogenic or antiestrogenic agents.
  • These compounds can inhibit breast cancer progression by affecting cell cycle regulation, gene expression, estrogen synthesis, and tumor growth pathways, and they also have the potential to reverse drug resistance.
  • Despite their low affinity for estrogen receptors, phytoestrogens and their derivatives show promise in breast cancer prevention and treatment through multiple molecular mechanisms, though further research on their structure-activity relationships is needed.
Read the full abstract

Top posts

Most liked on X and Bluesky
Daniela
@Noctilucahh · X

Además, aparentemente podrían inhibir, en cierto grado, la síntesis y metabolismo de los estrógenos. https://t.co/k80DfkSyzn https://t.co/Eyo0tpGZi6

Aug 9, 2020 · 1,712 followers View post →

All mentions

Daniela
@Noctilucahh · X

Además, aparentemente podrían inhibir, en cierto grado, la síntesis y metabolismo de los estrógenos. https://t.co/k80DfkSyzn https://t.co/Eyo0tpGZi6

Aug 9, 2020 · 1,712 followers View post →
Abstract Cancertiab Set | PDF | Melanoma | Polyunsaturated Fat
News

reserved. DOI: 10.1016/j.biopha.2023.115783. PMID: 37944439 [Indexed for ... 2018.08.100. Epub 2018 Sep 8. Phytoestrogens and breast cancer: In vitro ...

Dec 13, 2025 View →
Belastung der Ökosysteme | PZ – Pharmazeutische Zeitung
News

DOI: 10.1016/j.biopha.2018.08.100; Gore, A. C., et al., Executive ... DOI: 10.1016/j.beem.2021.101562; BfR, Endokrine Disruptoren: Ein ...

Oct 9, 2022 View →
Wie wirken endokrine Disruptoren | PZ – Pharmazeutische Zeitung
News

DOI: 10.1016/j.biopha.2018.08.100; Gore, A. C., et al., Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on ...

Oct 9, 2022 View →